These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2654792)

  • 21. Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone plus diphenhydramine in cisplatin-treated patients with ovarian cancer. Italian Group for Antiemetic Research.
    Support Care Cancer; 1994 May; 2(3):167-70. PubMed ID: 8032702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatin.
    Parikh PM; Charak BS; Banavali SD; Koppikar SB; Giri N; Nadkarni P; Saikia TK; Gopal R; Advani SH
    Cancer; 1988 Nov; 62(10):2263-6. PubMed ID: 3052785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.
    Kris MG; Gralla RJ; Tyson LB; Clark RA; Kelsen DP; Reilly LK; Groshen S; Bosl GJ; Kalman LA
    Cancer; 1985 Feb; 55(3):527-34. PubMed ID: 3880660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled clinical trial of the addition of transdermal scopolamine to a standard metoclopramide and dexamethasone antiemetic regimen.
    Meyer BR; O'Mara V; Reidenberg MM
    J Clin Oncol; 1987 Dec; 5(12):1994-7. PubMed ID: 3316518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis.
    Grunberg SM; Akerley WL; Krailo MD; Johnson KB; Baker CR; Cariffe PA
    Cancer Invest; 1986; 4(5):379-85. PubMed ID: 3801953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin].
    Culine S; Azab M; Pietri F; Ghosn M; Ben Amor B; Lupera H; Theodore C; Renaux J; Droz JP
    Bull Cancer; 1989; 76(6):583-9. PubMed ID: 2673437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of antiemetic activity of chloropromazine and high doses of metoclopramide in cisplatin-based chemotherapy.
    Tsavaris NB; Papaioannou D; Beldecos D; Kakoliris S; Mylonakis N; Karvounis N; Komitsopoulou P; Karagiaouris P; Sarmas J; Tzannou I
    Acta Oncol; 1990; 29(8):1005-9. PubMed ID: 2278720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapy.
    Niiranen A; Mattson K
    Am J Clin Oncol; 1987 Aug; 10(4):325-9. PubMed ID: 3039831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomized study comparing metoclopramide with chlorpromazine.
    Graham-Pole J; Weare J; Engel S; Gardner R; Mehta P; Gross S
    J Clin Oncol; 1986 Jul; 4(7):1110-3. PubMed ID: 3522818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
    J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination metoclopramide and dexamethasone: an effective antiemetic regimen in outpatients receiving non-cisplatin chemotherapy.
    Strum SB; McDermed JE; Streng BR; McDermott NM
    J Clin Oncol; 1984 Sep; 2(9):1057-63. PubMed ID: 6470755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved control of cisplatin-induced emesis with a metoclopramide-dexamethasone combination.
    Cognetti F; Pinnaro P; Carlini P; Caporali C; Ruggeri EM; Pollera CF
    Cancer Chemother Pharmacol; 1984; 13(3):235-7. PubMed ID: 6541533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil.
    Levitt M; Warr D; Yelle L; Rayner HL; Lofters WS; Perrault DJ; Wilson KS; Latreille J; Potvin M; Warner E
    N Engl J Med; 1993 Apr; 328(15):1081-4. PubMed ID: 8455665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alizapride alone or alizapride-dexamethasone compared with metoclopramide-dexamethasone in patients at high risk of acute emesis after cisplatin. A randomized cross-over study.
    Pollera CF; Nardi M; Marolla P; Calabresi F
    Acta Oncol; 1991; 30(6):725-9. PubMed ID: 1958393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomiting.
    Gagen M; Gochnour D; Young D; Gaginella T; Neidhart J
    J Clin Oncol; 1984 Jun; 2(6):696-701. PubMed ID: 6374059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antiemetic effects of combinations of metoclopramide, droperidol and dexamethasone for the prevention of cisplatin-induced gastro-intestinal toxicity: a randomized crossover trial].
    Fujii M; Kiura K; Kamei H; Okabe K; Toki H
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2257-61. PubMed ID: 3300561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.